1. NCD Risk Factor Collaboration (NCD-RisC). Prevalence of Obesity. Disponível em: https://www.worldobesity.org/about/about-obesity/prevalence-of-obesity. Acesso em: 16/12/2024.
2. World Obesity Federation, World Obesity Atlas 2023. Disponível em: [https://data.worldobesity.org/publications/?cat=19.](https://data.worldobesity.org/publications/?cat=19) Acesso em: 12/12/2024.
3. Novo Nordisk. Research and Technology Centres. Disponível em: https://www.novonordisk.com/science-and-technology/research-and-technology-centres.html. Acesso em: 12/12/2024.
4. Novo Nordisk. Annual Report 2023. Bagsværd: Novo Nordisk; 2023. Disponível em: https://www.novonordisk.com/content/dam/nncorp/global/en/investors/irmaterial/annual_report/2024/novo-nordisk-annual-report-2023.pdf. Acesso em: 12/12/2024.
5. World Health Organization (WHO) [Internet]. Obesity and overweight. Disponível em: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Acesso em: 12/12/2024.